Inspire Medical Systems, Inc. (NYSE:INSP) Shares Bought by New York State Common Retirement Fund

New York State Common Retirement Fund lifted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 23.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 182,750 shares of the company's stock after acquiring an additional 35,071 shares during the quarter. New York State Common Retirement Fund owned 0.61% of Inspire Medical Systems worth $29,108,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in INSP. Huntington National Bank boosted its holdings in Inspire Medical Systems by 228.3% during the fourth quarter. Huntington National Bank now owns 174 shares of the company's stock worth $32,000 after buying an additional 121 shares in the last quarter. True Wealth Design LLC boosted its holdings in Inspire Medical Systems by 39.0% during the fourth quarter. True Wealth Design LLC now owns 196 shares of the company's stock worth $36,000 after buying an additional 55 shares in the last quarter. Harbour Investments Inc. boosted its holdings in Inspire Medical Systems by 101.0% during the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after buying an additional 99 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Inspire Medical Systems by 356.5% during the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock worth $33,000 after buying an additional 164 shares in the last quarter. Finally, AlphaQuest LLC boosted its holdings in Inspire Medical Systems by 7,275.0% during the fourth quarter. AlphaQuest LLC now owns 295 shares of the company's stock worth $55,000 after buying an additional 291 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

Insider Activity at Inspire Medical Systems

In related news, Director Shawn Mccormick sold 360 shares of the company's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total value of $57,600.00. Following the completion of the sale, the director owned 24,046 shares in the company, valued at $3,847,360. This represents a 1.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 4.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

INSP has been the topic of several recent analyst reports. Morgan Stanley decreased their price objective on shares of Inspire Medical Systems from $200.00 to $182.00 and set an "overweight" rating on the stock in a report on Tuesday. Robert W. Baird increased their price objective on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a report on Tuesday, May 6th. JPMorgan Chase & Co. decreased their price objective on shares of Inspire Medical Systems from $235.00 to $195.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. KeyCorp reduced their target price on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Wall Street Zen upgraded shares of Inspire Medical Systems from a "hold" rating to a "buy" rating in a research report on Saturday, July 12th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $210.27.

Inspire Medical Systems Stock Down 0.6%

Inspire Medical Systems stock traded down $0.78 during trading on Friday, reaching $127.19. The stock had a trading volume of 207,413 shares, compared to its average volume of 558,337. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $225.00. The business has a 50 day moving average price of $136.73 and a 200 day moving average price of $160.03. The stock has a market cap of $3.75 billion, a PE ratio of 58.76, a P/E/G ratio of 1.95 and a beta of 1.25.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.33. The business had revenue of $201.32 million during the quarter, compared to the consensus estimate of $194.89 million. Inspire Medical Systems had a net margin of 7.92% and a return on equity of 10.00%. The company's revenue was up 22.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.34) EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.